 | • レポートコード：QYR2104Z3490 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、肺がん診断検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（イムノアッセイ、フローサイトメトリー、迅速検査、分子アッセイ、組織アレイ、循環腫瘍細胞、薬理診断、バイオマーカー、その他診断方法）、用途別市場規模（精密医療、個別化医療、がんモニタリング）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・肺がん診断検査の市場動向 ・企業の競争状況、市場シェア ・肺がん診断検査の種類別市場規模（イムノアッセイ、フローサイトメトリー、迅速検査、分子アッセイ、組織アレイ、循環腫瘍細胞、薬理診断、バイオマーカー、その他診断方法） ・肺がん診断検査の用途別市場規模（精密医療、個別化医療、がんモニタリング） ・肺がん診断検査の北米市場規模2016-2027（アメリカ、カナダ） ・肺がん診断検査のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・肺がん診断検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・肺がん診断検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・肺がん診断検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Advpharma Inc、AIT Austrian Institute of Technology GmbH、Courtagen Life Sciences Inc、DiagnoCure Inc. (Inactive)、BioMark Diagnostics Inc.、BioMarker Strategies LLC、Emory University、Epigenomics AG、GlycoZym、HalioDx SAS、Louisville Bioscience, Inc.、Mayo Clinic US） ・結論 |
Market Analysis and Insights: Global Lung Cancer Diagnostic Tests Market
The global Lung Cancer Diagnostic Tests market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Lung Cancer Diagnostic Tests market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Lung Cancer Diagnostic Tests market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Lung Cancer Diagnostic Tests market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Lung Cancer Diagnostic Tests market.
Global Lung Cancer Diagnostic Tests Scope and Market Size
Lung Cancer Diagnostic Tests market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Lung Cancer Diagnostic Tests market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Immunoassays
Flow Cytometry
Rapid Tests
Molecular Assays
Tissue Arrays
Circulating Tumor Cells
Pharmacodiagnostics
Biomarkers
Other Diagnostics Methods
Segment by Application
Precision Medicine
Personalized Medicine
Cancer Monitoring
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Advpharma Inc
AIT Austrian Institute of Technology GmbH
Courtagen Life Sciences Inc
DiagnoCure Inc. (Inactive)
BioMark Diagnostics Inc.
BioMarker Strategies LLC
Emory University
Epigenomics AG
GlycoZym
DiagnoCure Inc. (Inactive)
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lung Cancer Diagnostic Tests Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Immunoassays
1.2.3 Flow Cytometry
1.2.4 Rapid Tests
1.2.5 Molecular Assays
1.2.6 Tissue Arrays
1.2.7 Circulating Tumor Cells
1.2.8 Pharmacodiagnostics
1.2.9 Biomarkers
1.2.10 Other Diagnostics Methods
1.3 Market by Application
1.3.1 Global Lung Cancer Diagnostic Tests Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Precision Medicine
1.3.3 Personalized Medicine
1.3.4 Cancer Monitoring
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Lung Cancer Diagnostic Tests Market Perspective (2016-2027)
2.2 Lung Cancer Diagnostic Tests Growth Trends by Regions
2.2.1 Lung Cancer Diagnostic Tests Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Lung Cancer Diagnostic Tests Historic Market Share by Regions (2016-2021)
2.2.3 Lung Cancer Diagnostic Tests Forecasted Market Size by Regions (2022-2027)
2.3 Lung Cancer Diagnostic Tests Industry Dynamic
2.3.1 Lung Cancer Diagnostic Tests Market Trends
2.3.2 Lung Cancer Diagnostic Tests Market Drivers
2.3.3 Lung Cancer Diagnostic Tests Market Challenges
2.3.4 Lung Cancer Diagnostic Tests Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lung Cancer Diagnostic Tests Players by Revenue
3.1.1 Global Top Lung Cancer Diagnostic Tests Players by Revenue (2016-2021)
3.1.2 Global Lung Cancer Diagnostic Tests Revenue Market Share by Players (2016-2021)
3.2 Global Lung Cancer Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Lung Cancer Diagnostic Tests Revenue
3.4 Global Lung Cancer Diagnostic Tests Market Concentration Ratio
3.4.1 Global Lung Cancer Diagnostic Tests Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Diagnostic Tests Revenue in 2020
3.5 Lung Cancer Diagnostic Tests Key Players Head office and Area Served
3.6 Key Players Lung Cancer Diagnostic Tests Product Solution and Service
3.7 Date of Enter into Lung Cancer Diagnostic Tests Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Lung Cancer Diagnostic Tests Breakdown Data by Type
4.1 Global Lung Cancer Diagnostic Tests Historic Market Size by Type (2016-2021)
4.2 Global Lung Cancer Diagnostic Tests Forecasted Market Size by Type (2022-2027)
5 Lung Cancer Diagnostic Tests Breakdown Data by Application
5.1 Global Lung Cancer Diagnostic Tests Historic Market Size by Application (2016-2021)
5.2 Global Lung Cancer Diagnostic Tests Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Lung Cancer Diagnostic Tests Market Size (2016-2027)
6.2 North America Lung Cancer Diagnostic Tests Market Size by Type
6.2.1 North America Lung Cancer Diagnostic Tests Market Size by Type (2016-2021)
6.2.2 North America Lung Cancer Diagnostic Tests Market Size by Type (2022-2027)
6.2.3 North America Lung Cancer Diagnostic Tests Market Size by Type (2016-2027)
6.3 North America Lung Cancer Diagnostic Tests Market Size by Application
6.3.1 North America Lung Cancer Diagnostic Tests Market Size by Application (2016-2021)
6.3.2 North America Lung Cancer Diagnostic Tests Market Size by Application (2022-2027)
6.3.3 North America Lung Cancer Diagnostic Tests Market Size by Application (2016-2027)
6.4 North America Lung Cancer Diagnostic Tests Market Size by Country
6.4.1 North America Lung Cancer Diagnostic Tests Market Size by Country (2016-2021)
6.4.2 North America Lung Cancer Diagnostic Tests Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Lung Cancer Diagnostic Tests Market Size (2016-2027)
7.2 Europe Lung Cancer Diagnostic Tests Market Size by Type
7.2.1 Europe Lung Cancer Diagnostic Tests Market Size by Type (2016-2021)
7.2.2 Europe Lung Cancer Diagnostic Tests Market Size by Type (2022-2027)
7.2.3 Europe Lung Cancer Diagnostic Tests Market Size by Type (2016-2027)
7.3 Europe Lung Cancer Diagnostic Tests Market Size by Application
7.3.1 Europe Lung Cancer Diagnostic Tests Market Size by Application (2016-2021)
7.3.2 Europe Lung Cancer Diagnostic Tests Market Size by Application (2022-2027)
7.3.3 Europe Lung Cancer Diagnostic Tests Market Size by Application (2016-2027)
7.4 Europe Lung Cancer Diagnostic Tests Market Size by Country
7.4.1 Europe Lung Cancer Diagnostic Tests Market Size by Country (2016-2021)
7.4.2 Europe Lung Cancer Diagnostic Tests Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Lung Cancer Diagnostic Tests Market Size (2016-2027)
8.2 Asia-Pacific Lung Cancer Diagnostic Tests Market Size by Type
8.2.1 Asia-Pacific Lung Cancer Diagnostic Tests Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Lung Cancer Diagnostic Tests Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Lung Cancer Diagnostic Tests Market Size by Type (2016-2027)
8.3 Asia-Pacific Lung Cancer Diagnostic Tests Market Size by Application
8.3.1 Asia-Pacific Lung Cancer Diagnostic Tests Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Lung Cancer Diagnostic Tests Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Lung Cancer Diagnostic Tests Market Size by Application (2016-2027)
8.4 Asia-Pacific Lung Cancer Diagnostic Tests Market Size by Region
8.4.1 Asia-Pacific Lung Cancer Diagnostic Tests Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Lung Cancer Diagnostic Tests Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Lung Cancer Diagnostic Tests Market Size (2016-2027)
9.2 Latin America Lung Cancer Diagnostic Tests Market Size by Type
9.2.1 Latin America Lung Cancer Diagnostic Tests Market Size by Type (2016-2021)
9.2.2 Latin America Lung Cancer Diagnostic Tests Market Size by Type (2022-2027)
9.2.3 Latin America Lung Cancer Diagnostic Tests Market Size by Type (2016-2027)
9.3 Latin America Lung Cancer Diagnostic Tests Market Size by Application
9.3.1 Latin America Lung Cancer Diagnostic Tests Market Size by Application (2016-2021)
9.3.2 Latin America Lung Cancer Diagnostic Tests Market Size by Application (2022-2027)
9.3.3 Latin America Lung Cancer Diagnostic Tests Market Size by Application (2016-2027)
9.4 Latin America Lung Cancer Diagnostic Tests Market Size by Country
9.4.1 Latin America Lung Cancer Diagnostic Tests Market Size by Country (2016-2021)
9.4.2 Latin America Lung Cancer Diagnostic Tests Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lung Cancer Diagnostic Tests Market Size (2016-2027)
10.2 Middle East & Africa Lung Cancer Diagnostic Tests Market Size by Type
10.2.1 Middle East & Africa Lung Cancer Diagnostic Tests Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Lung Cancer Diagnostic Tests Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Lung Cancer Diagnostic Tests Market Size by Type (2016-2027)
10.3 Middle East & Africa Lung Cancer Diagnostic Tests Market Size by Application
10.3.1 Middle East & Africa Lung Cancer Diagnostic Tests Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Lung Cancer Diagnostic Tests Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Lung Cancer Diagnostic Tests Market Size by Application (2016-2027)
10.4 Middle East & Africa Lung Cancer Diagnostic Tests Market Size by Country
10.4.1 Middle East & Africa Lung Cancer Diagnostic Tests Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Lung Cancer Diagnostic Tests Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Advpharma Inc
11.1.1 Advpharma Inc Company Details
11.1.2 Advpharma Inc Business Overview
11.1.3 Advpharma Inc Lung Cancer Diagnostic Tests Introduction
11.1.4 Advpharma Inc Revenue in Lung Cancer Diagnostic Tests Business (2016-2021)
11.1.5 Advpharma Inc Recent Development
11.2 AIT Austrian Institute of Technology GmbH
11.2.1 AIT Austrian Institute of Technology GmbH Company Details
11.2.2 AIT Austrian Institute of Technology GmbH Business Overview
11.2.3 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Introduction
11.2.4 AIT Austrian Institute of Technology GmbH Revenue in Lung Cancer Diagnostic Tests Business (2016-2021)
11.2.5 AIT Austrian Institute of Technology GmbH Recent Development
11.3 Courtagen Life Sciences Inc
11.3.1 Courtagen Life Sciences Inc Company Details
11.3.2 Courtagen Life Sciences Inc Business Overview
11.3.3 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Introduction
11.3.4 Courtagen Life Sciences Inc Revenue in Lung Cancer Diagnostic Tests Business (2016-2021)
11.3.5 Courtagen Life Sciences Inc Recent Development
11.4 DiagnoCure Inc. (Inactive)
11.4.1 DiagnoCure Inc. (Inactive) Company Details
11.4.2 DiagnoCure Inc. (Inactive) Business Overview
11.4.3 DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Introduction
11.4.4 DiagnoCure Inc. (Inactive) Revenue in Lung Cancer Diagnostic Tests Business (2016-2021)
11.4.5 DiagnoCure Inc. (Inactive) Recent Development
11.5 BioMark Diagnostics Inc.
11.5.1 BioMark Diagnostics Inc. Company Details
11.5.2 BioMark Diagnostics Inc. Business Overview
11.5.3 BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Introduction
11.5.4 BioMark Diagnostics Inc. Revenue in Lung Cancer Diagnostic Tests Business (2016-2021)
11.5.5 BioMark Diagnostics Inc. Recent Development
11.6 BioMarker Strategies LLC
11.6.1 BioMarker Strategies LLC Company Details
11.6.2 BioMarker Strategies LLC Business Overview
11.6.3 BioMarker Strategies LLC Lung Cancer Diagnostic Tests Introduction
11.6.4 BioMarker Strategies LLC Revenue in Lung Cancer Diagnostic Tests Business (2016-2021)
11.6.5 BioMarker Strategies LLC Recent Development
11.7 Emory University
11.7.1 Emory University Company Details
11.7.2 Emory University Business Overview
11.7.3 Emory University Lung Cancer Diagnostic Tests Introduction
11.7.4 Emory University Revenue in Lung Cancer Diagnostic Tests Business (2016-2021)
11.7.5 Emory University Recent Development
11.8 Epigenomics AG
11.8.1 Epigenomics AG Company Details
11.8.2 Epigenomics AG Business Overview
11.8.3 Epigenomics AG Lung Cancer Diagnostic Tests Introduction
11.8.4 Epigenomics AG Revenue in Lung Cancer Diagnostic Tests Business (2016-2021)
11.8.5 Epigenomics AG Recent Development
11.9 GlycoZym
11.9.1 GlycoZym Company Details
11.9.2 GlycoZym Business Overview
11.9.3 GlycoZym Lung Cancer Diagnostic Tests Introduction
11.9.4 GlycoZym Revenue in Lung Cancer Diagnostic Tests Business (2016-2021)
11.9.5 GlycoZym Recent Development
11.10 HalioDx SAS
11.10.1 HalioDx SAS Company Details
11.10.2 HalioDx SAS Business Overview
11.10.3 HalioDx SAS Lung Cancer Diagnostic Tests Introduction
11.10.4 HalioDx SAS Revenue in Lung Cancer Diagnostic Tests Business (2016-2021)
11.10.5 HalioDx SAS Recent Development
11.11 Louisville Bioscience, Inc.
11.11.1 Louisville Bioscience, Inc. Company Details
11.11.2 Louisville Bioscience, Inc. Business Overview
11.11.3 Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Introduction
11.11.4 Louisville Bioscience, Inc. Revenue in Lung Cancer Diagnostic Tests Business (2016-2021)
11.11.5 Louisville Bioscience, Inc. Recent Development
11.12 Mayo Clinic US
11.12.1 Mayo Clinic US Company Details
11.12.2 Mayo Clinic US Business Overview
11.12.3 Mayo Clinic US Lung Cancer Diagnostic Tests Introduction
11.12.4 Mayo Clinic US Revenue in Lung Cancer Diagnostic Tests Business (2016-2021)
11.12.5 Mayo Clinic US Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Lung Cancer Diagnostic Tests Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Immunoassays
Table 3. Key Players of Flow Cytometry
Table 4. Key Players of Rapid Tests
Table 5. Key Players of Molecular Assays
Table 6. Key Players of Tissue Arrays
Table 7. Key Players of Circulating Tumor Cells
Table 8. Key Players of Pharmacodiagnostics
Table 9. Key Players of Biomarkers
Table 10. Key Players of Other Diagnostics Methods
Table 11. Global Lung Cancer Diagnostic Tests Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Lung Cancer Diagnostic Tests Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 13. Global Lung Cancer Diagnostic Tests Market Size by Regions (2016-2021) & (US$ Million)
Table 14. Global Lung Cancer Diagnostic Tests Market Share by Regions (2016-2021)
Table 15. Global Lung Cancer Diagnostic Tests Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 16. Global Lung Cancer Diagnostic Tests Market Share by Regions (2022-2027)
Table 17. Lung Cancer Diagnostic Tests Market Trends
Table 18. Lung Cancer Diagnostic Tests Market Drivers
Table 19. Lung Cancer Diagnostic Tests Market Challenges
Table 20. Lung Cancer Diagnostic Tests Market Restraints
Table 21. Global Lung Cancer Diagnostic Tests Revenue by Players (2016-2021) & (US$ Million)
Table 22. Global Lung Cancer Diagnostic Tests Market Share by Players (2016-2021)
Table 23. Global Top Lung Cancer Diagnostic Tests Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Diagnostic Tests as of 2020)
Table 24. Ranking of Global Top Lung Cancer Diagnostic Tests Companies by Revenue (US$ Million) in 2020
Table 25. Global 5 Largest Players Market Share by Lung Cancer Diagnostic Tests Revenue (CR5 and HHI) & (2016-2021)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Lung Cancer Diagnostic Tests Product Solution and Service
Table 28. Date of Enter into Lung Cancer Diagnostic Tests Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Lung Cancer Diagnostic Tests Market Size by Type (2016-2021) (US$ Million)
Table 31. Global Lung Cancer Diagnostic Tests Revenue Market Share by Type (2016-2021)
Table 32. Global Lung Cancer Diagnostic Tests Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 33. Global Lung Cancer Diagnostic Tests Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 34. Global Lung Cancer Diagnostic Tests Market Size Share by Application (2016-2021) & (US$ Million)
Table 35. Global Lung Cancer Diagnostic Tests Revenue Market Share by Application (2016-2021)
Table 36. Global Lung Cancer Diagnostic Tests Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 37. Global Lung Cancer Diagnostic Tests Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 38. North America Lung Cancer Diagnostic Tests Market Size by Type (2016-2021) (US$ Million)
Table 39. North America Lung Cancer Diagnostic Tests Market Size by Type (2022-2027) & (US$ Million)
Table 40. North America Lung Cancer Diagnostic Tests Market Size by Application (2016-2021) (US$ Million)
Table 41. North America Lung Cancer Diagnostic Tests Market Size by Application (2022-2027) & (US$ Million)
Table 42. North America Lung Cancer Diagnostic Tests Market Size by Country (2016-2021) & (US$ Million)
Table 43. North America Lung Cancer Diagnostic Tests Market Size by Country (2022-2027) & (US$ Million)
Table 44. Europe Lung Cancer Diagnostic Tests Market Size by Type (2016-2021) (US$ Million)
Table 45. Europe Lung Cancer Diagnostic Tests Market Size by Type (2022-2027) & (US$ Million)
Table 46. Europe Lung Cancer Diagnostic Tests Market Size by Application (2016-2021) (US$ Million)
Table 47. Europe Lung Cancer Diagnostic Tests Market Size by Application (2022-2027) & (US$ Million)
Table 48. Europe Lung Cancer Diagnostic Tests Market Size by Country (2016-2021) & (US$ Million)
Table 49. Europe Lung Cancer Diagnostic Tests Market Size by Country (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Lung Cancer Diagnostic Tests Market Size by Type (2016-2021) (US$ Million)
Table 51. Asia-Pacific Lung Cancer Diagnostic Tests Market Size by Type (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Lung Cancer Diagnostic Tests Market Size by Application (2016-2021) (US$ Million)
Table 53. Asia-Pacific Lung Cancer Diagnostic Tests Market Size by Application (2022-2027) & (US$ Million)
Table 54. Asia-Pacific Lung Cancer Diagnostic Tests Market Size by Region (2016-2021) & (US$ Million)
Table 55. Asia-Pacific Lung Cancer Diagnostic Tests Market Size by Region (2022-2027) & (US$ Million)
Table 56. Latin America Lung Cancer Diagnostic Tests Market Size by Type (2016-2021) (US$ Million)
Table 57. Latin America Lung Cancer Diagnostic Tests Market Size by Type (2022-2027) & (US$ Million)
Table 58. Latin America Lung Cancer Diagnostic Tests Market Size by Application (2016-2021) (US$ Million)
Table 59. Latin America Lung Cancer Diagnostic Tests Market Size by Application (2022-2027) & (US$ Million)
Table 60. Latin America Lung Cancer Diagnostic Tests Market Size by Country (2016-2021) & (US$ Million)
Table 61. Latin America Lung Cancer Diagnostic Tests Market Size by Country (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Lung Cancer Diagnostic Tests Market Size by Type (2016-2021) (US$ Million)
Table 63. Middle East & Africa Lung Cancer Diagnostic Tests Market Size by Type (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Lung Cancer Diagnostic Tests Market Size by Application (2016-2021) (US$ Million)
Table 65. Middle East & Africa Lung Cancer Diagnostic Tests Market Size by Application (2022-2027) & (US$ Million)
Table 66. Middle East & Africa Lung Cancer Diagnostic Tests Market Size by Country (2016-2021) & (US$ Million)
Table 67. Middle East & Africa Lung Cancer Diagnostic Tests Market Size by Country (2022-2027) & (US$ Million)
Table 68. Advpharma Inc Company Details
Table 69. Advpharma Inc Business Overview
Table 70. Advpharma Inc Lung Cancer Diagnostic Tests Product
Table 71. Advpharma Inc Revenue in Lung Cancer Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 72. Advpharma Inc Recent Development
Table 73. AIT Austrian Institute of Technology GmbH Company Details
Table 74. AIT Austrian Institute of Technology GmbH Business Overview
Table 75. AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Product
Table 76. AIT Austrian Institute of Technology GmbH Revenue in Lung Cancer Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 77. AIT Austrian Institute of Technology GmbH Recent Development
Table 78. Courtagen Life Sciences Inc Company Details
Table 79. Courtagen Life Sciences Inc Business Overview
Table 80. Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Product
Table 81. Courtagen Life Sciences Inc Revenue in Lung Cancer Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 82. Courtagen Life Sciences Inc Recent Development
Table 83. DiagnoCure Inc. (Inactive) Company Details
Table 84. DiagnoCure Inc. (Inactive) Business Overview
Table 85. DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Product
Table 86. DiagnoCure Inc. (Inactive) Revenue in Lung Cancer Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 87. DiagnoCure Inc. (Inactive) Recent Development
Table 88. BioMark Diagnostics Inc. Company Details
Table 89. BioMark Diagnostics Inc. Business Overview
Table 90. BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Product
Table 91. BioMark Diagnostics Inc. Revenue in Lung Cancer Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 92. BioMark Diagnostics Inc. Recent Development
Table 93. BioMarker Strategies LLC Company Details
Table 94. BioMarker Strategies LLC Business Overview
Table 95. BioMarker Strategies LLC Lung Cancer Diagnostic Tests Product
Table 96. BioMarker Strategies LLC Revenue in Lung Cancer Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 97. BioMarker Strategies LLC Recent Development
Table 98. Emory University Company Details
Table 99. Emory University Business Overview
Table 100. Emory University Lung Cancer Diagnostic Tests Product
Table 101. Emory University Revenue in Lung Cancer Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 102. Emory University Recent Development
Table 103. Epigenomics AG Company Details
Table 104. Epigenomics AG Business Overview
Table 105. Epigenomics AG Revenue in Lung Cancer Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 106. Epigenomics AG Recent Development
Table 107. GlycoZym Company Details
Table 108. GlycoZym Business Overview
Table 109. GlycoZym Lung Cancer Diagnostic Tests Product
Table 110. GlycoZym Revenue in Lung Cancer Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 111. GlycoZym Recent Development
Table 112. HalioDx SAS Company Details
Table 113. HalioDx SAS Business Overview
Table 114. HalioDx SAS Lung Cancer Diagnostic Tests Product
Table 115. HalioDx SAS Revenue in Lung Cancer Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 116. HalioDx SAS Recent Development
Table 117. Louisville Bioscience, Inc. Company Details
Table 118. Louisville Bioscience, Inc. Business Overview
Table 119. Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Product
Table 120. Louisville Bioscience, Inc. Revenue in Lung Cancer Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 121. Louisville Bioscience, Inc. Recent Development
Table 122. Mayo Clinic US Company Details
Table 123. Mayo Clinic US Business Overview
Table 124. Mayo Clinic US Lung Cancer Diagnostic Tests Product
Table 125. Mayo Clinic US Revenue in Lung Cancer Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 126. Mayo Clinic US Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lung Cancer Diagnostic Tests Market Share by Type: 2020 VS 2027
Figure 2. Immunoassays Features
Figure 3. Flow Cytometry Features
Figure 4. Rapid Tests Features
Figure 5. Molecular Assays Features
Figure 6. Tissue Arrays Features
Figure 7. Circulating Tumor Cells Features
Figure 8. Pharmacodiagnostics Features
Figure 9. Biomarkers Features
Figure 10. Other Diagnostics Methods Features
Figure 11. Global Lung Cancer Diagnostic Tests Market Share by Application: 2020 VS 2027
Figure 12. Precision Medicine Case Studies
Figure 13. Personalized Medicine Case Studies
Figure 14. Cancer Monitoring Case Studies
Figure 15. Lung Cancer Diagnostic Tests Report Years Considered
Figure 16. Global Lung Cancer Diagnostic Tests Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 17. Global Lung Cancer Diagnostic Tests Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Lung Cancer Diagnostic Tests Market Share by Regions: 2020 VS 2027
Figure 19. Global Lung Cancer Diagnostic Tests Market Share by Regions (2022-2027)
Figure 20. Global Lung Cancer Diagnostic Tests Market Share by Players in 2020
Figure 21. Global Top Lung Cancer Diagnostic Tests Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Diagnostic Tests as of 2020
Figure 22. The Top 10 and 5 Players Market Share by Lung Cancer Diagnostic Tests Revenue in 2020
Figure 23. Global Lung Cancer Diagnostic Tests Revenue Market Share by Type (2016-2021)
Figure 24. Global Lung Cancer Diagnostic Tests Revenue Market Share by Type (2022-2027)
Figure 25. North America Lung Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. North America Lung Cancer Diagnostic Tests Market Share by Type (2016-2027)
Figure 27. North America Lung Cancer Diagnostic Tests Market Share by Application (2016-2027)
Figure 28. North America Lung Cancer Diagnostic Tests Market Share by Country (2016-2027)
Figure 29. United States Lung Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Canada Lung Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Lung Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Lung Cancer Diagnostic Tests Market Share by Type (2016-2027)
Figure 33. Europe Lung Cancer Diagnostic Tests Market Share by Application (2016-2027)
Figure 34. Europe Lung Cancer Diagnostic Tests Market Share by Country (2016-2027)
Figure 35. Germany Lung Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. France Lung Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. U.K. Lung Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Italy Lung Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Russia Lung Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Nordic Lung Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Lung Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Lung Cancer Diagnostic Tests Market Share by Type (2016-2027)
Figure 43. Asia-Pacific Lung Cancer Diagnostic Tests Market Share by Application (2016-2027)
Figure 44. Asia-Pacific Lung Cancer Diagnostic Tests Market Share by Region (2016-2027)
Figure 45. China Lung Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Japan Lung Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. South Korea Lung Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Southeast Asia Lung Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. India Lung Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Australia Lung Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Lung Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Lung Cancer Diagnostic Tests Market Share by Type (2016-2027)
Figure 53. Latin America Lung Cancer Diagnostic Tests Market Share by Application (2016-2027)
Figure 54. Latin America Lung Cancer Diagnostic Tests Market Share by Country (2016-2027)
Figure 55. Mexico Lung Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Brazil Lung Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Lung Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Lung Cancer Diagnostic Tests Market Share by Type (2016-2027)
Figure 59. Middle East & Africa Lung Cancer Diagnostic Tests Market Share by Application (2016-2027)
Figure 60. Middle East & Africa Lung Cancer Diagnostic Tests Market Share by Country (2016-2027)
Figure 61. Turkey Lung Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Saudi Arabia Lung Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. UAE Lung Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Advpharma Inc Revenue Growth Rate in Lung Cancer Diagnostic Tests Business (2016-2021)
Figure 65. AIT Austrian Institute of Technology GmbH Revenue Growth Rate in Lung Cancer Diagnostic Tests Business (2016-2021)
Figure 66. Courtagen Life Sciences Inc Revenue Growth Rate in Lung Cancer Diagnostic Tests Business (2016-2021)
Figure 67. DiagnoCure Inc. (Inactive) Revenue Growth Rate in Lung Cancer Diagnostic Tests Business (2016-2021)
Figure 68. BioMark Diagnostics Inc. Revenue Growth Rate in Lung Cancer Diagnostic Tests Business (2016-2021)
Figure 69. BioMarker Strategies LLC Revenue Growth Rate in Lung Cancer Diagnostic Tests Business (2016-2021)
Figure 70. Emory University Revenue Growth Rate in Lung Cancer Diagnostic Tests Business (2016-2021)
Figure 71. Epigenomics AG Revenue Growth Rate in Lung Cancer Diagnostic Tests Business (2016-2021)
Figure 72. GlycoZym Revenue Growth Rate in Lung Cancer Diagnostic Tests Business (2016-2021)
Figure 73. HalioDx SAS Revenue Growth Rate in Lung Cancer Diagnostic Tests Business (2016-2021)
Figure 74. Louisville Bioscience, Inc. Revenue Growth Rate in Lung Cancer Diagnostic Tests Business (2016-2021)
Figure 75. Mayo Clinic US Revenue Growth Rate in Lung Cancer Diagnostic Tests Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
世界の子宮頸がん診断検査市場規模・現状・予測（2021年-2027年） Cervical cancer is a cancer arising from the cervix. It is due to the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Market Analysis and Insights: Global Cervical Cancer Diagnostic Tests Market The global Cervical Cancer Diagnostic Tests market size is…- 世界のマラリア迅速診断検査（RDT）市場規模・現状・予測（2021年-2027年） Malaria rapid diagnostic tests (RDTs) assist in the diagnosis of malaria by detecting evidence of malaria parasites (antigens) in human blood. RDTs permit a reliable detection of malaria infections particularly in remote areas with limited access to good quality microscopy services. Market Analysis …
- 世界のマラリア迅速診断検査（RDT）市場規模・現状・予測（2021年-2027年） Malaria rapid diagnostic tests (RDTs) assist in the diagnosis of malaria by detecting evidence of malaria parasites (antigens) in human blood. RDTs permit a reliable detection of malaria infections particularly in remote areas with limited access to good quality microscopy services. Market Analysis …
- 世界の循環腫瘍細胞（CTC）・がん幹細胞（CSC）市場規模・現状・予測（2021年-2027年） The tumor cells which have shed into lymphatic system and circulated over the body through blood circulation are called as circulating tumor cells. Circulating tumor cells may comprise seeds for metastasis. Stem cells are the type of cells that can differentiate into specialized cells and have the c…
- 世界のマラリア迅速診断検査（RDT）市場 2021：企業別、地域別、種類・用途別 The Malaria rapid diagnostic tests (RDTs) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…